Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

April 21, 2021, 4:31 p.m. EDT

Moderna Inc. stock outperforms competitors on strong trading day

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA rallied 8.11% to $169.50 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.19% to 13,950.22 and the Dow Jones Industrial Average DJIA rising 0.93% to 34,137.31. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $19.76 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock outperformed some of its competitors Wednesday, as AbbVie Inc. ABBV rose 1.62% to $110.80, Amgen Inc. AMGN fell 0.14% to $258.78, and AstraZeneca PLC ADR AZN rose 1.61% to $53.11. Trading volume (11.3 M) eclipsed its 50-day average volume of 8.9 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.